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Abstract: At present, there are still a lot of diseases pathogenesis not clear, but making use of a new generation of se-
quencing technology to organisms conduct whole genome sequencing, which for the pathogenesis of many diseases 
provide a new theoretical basis. So, Which aspects the whole genome sequencing in medical use? In this article, I got 
through reading the whole genome sequencing of research papers about abroad nearly five years finding that the whole 
genome sequencing could be widely used in genetic disease, tumor, infectious diseases, infectious epidemic, judge the 
individual susceptibility to disease, the diagnosis and treatment of a variety of diseases such as biological evolution. 
This paper reviewed the whole genome sequencing progress in medical application from a genetic disease, tumor, infec-
tious diseases, infectious epidemic, determine the individual susceptibility and biological evolution. 
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The genome refers to all the genetic material of living organisms, organelles or viruses. Whole-genome sequencing 
is a new generation of high-throughput DNA sequencing tools to analyze the structural differences between genomes of 
different organisms by means of bioinformatics, and to complete the annotation of single nucleotide polymorphism 
(SNP) and genome structure. Next generation sequencing (NGS) technology, combined with new pattern recognition 
methods and network analysis, has radically changed the understanding of basic biological mechanisms and cellular 
pathways. Whole genome sequencing provides a new method for gene diagnosis, making it easier to find gene mutants, 
which opens up a new way for gene therapy. Gene diagnosis and gene therapy are widely used in genetic diseases, tu-
mors, infectious diseases, infectious epidemics, judging individual disease susceptibility, biological evolution and other 
fields. This provides a new basis for the prevention, diagnosis and treatment of many diseases, and also brings good 
news for many patients. This article will review the progress of whole genome sequencing in medical applications. 
1. Genome sequencing in medical applications 
The new generation of genome-wide sequencing has made genome-wide sequencing widely used in cancer, genetic 
diseases, infectious epidemics, infectious diseases and other diseases, as well as to determine the susceptibility of indi-
vidual diseases and biological evolution. 
1.1 Genetic diseases 
Using whole genome sequencing, new mutants of genetic diseases were found, which provided new theoretical ba-
sis for the pathogenesis of genetic diseases. 
(1) Funayama et al. (2015) detected by next-generation sequencing technology.A new missense mutation 
CHCHD2 was found in the genome of 340 independent families with autosomal dominant Parkinson's disease, 517 
sporadic Parkinson's disease, and 559 controls. It is speculated that this mutation may be the cause of autosomal domi-
nant Park- 
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inson's disease. 
(2) Nemirovsky et al. (2015) genome-wide sequencing of three autism spectrum disorder (ASD) patients and their 
parents and the use of the most advanced integrated bioinformatics to analyze transmission pathways and prioritize the 
location of mutations in the gene and the possible relationship with ASD, and Sanger sequencing was used to test them. 
Confirmation test results showed that exon 21 of SHANK3 gene was missing a heterozygous cytosine chimeric, result-
ing in a missense sequence of five codons after the termination codon. This mutation may be associated with autism 
spectrum disorder. 
(3) Using the second-generation sequencing technique, the researchers sequenced the entire genome of a soybean 
caryophyllum ecological model mutated by ethyl methylsulfonate and analyzed its third-generation offspring. A low 
percentage of prejudiced mutations G/C to A/T (Mohd) were found in each single nucleotide at 208 KB (AS) and 202 
KB (AM) intervals. -Yusoff et al., 2015). Therefore, genome-wide sequencing of genetic diseases provides a new mo-
lecular approach to the etiology of diseases and provides a new direction for the prevention and treatment of these dis-
eases. 
1.2 Tumor 
Tumor is a hotspot and difficult point in current research. Genome-wide sequencing has made great contributions 
to the discovery, risk factors, prognosis, treatment and drug resistance mechanism of many tumors, and laid a solid 
foundation for the search for the etiology and radical treatment of tumors. 
(1) MRoz et al. (2015) calculated the tumor mutation allele heterogeneity of 305 head and neck squamous cell car-
cinoma patients (clinical and genome-wide sequencing data obtained from the Tumor Genome Project in October 2013) 
using genome-wide sequencing results. High mutation allele tumor heterogeneity was found to be substantially associ-
ated with reduced overall survival Hazard ratio analysis: hazard ratio is high / low heterogeneity =2.2 (95% CI1.4-3.3). 
(2) Genome-wide sequencing and exome-wide sequencing of 252 untreated GBM patients from the cancer genome 
map, 21 GBM patients with first pair recurrence and 2 GBM patients with second pair recurrence revealed that the p53 
gene pathway was altered by a high number of subgroups of malignant gliomas. Clonal mutation is a major predictor of 
molecular events, but can be broadly classified as linear recurrence and sporadic recurrence. Linear recurrence shares 
extensive genetic similarities with primary tumors and can be directly traced back to one of the characteristics of pri-
mary tumors. Branched cells occur, which suggests that genetic changes in primary tumors affect subsequent tumor cell 
evolution and subclonal heterogeneity (Kim et al., 2015). 
(3) the researchers analyzed 104 new cases by whole genome sequencing. 
Clinical findings from 168 patients with prostate cancer and 168 elderly patients with renewed primary prostate 
cancer showed that DNA copy num-ber alteration (CAN) load (the percentage of the cancer genome affected by DNA 
copy num ber changes) was associated with recurrence of primary prostate cancer. The results demonstrated that 
low-cost use was associated with recurrence of primary prostate cancer. Genome-wide sequencing needle biopsy exam-
ines the CAN load to prepare for the prognosis of conservative treatment groups (Hieronymus et al., 2014). 
(4) Fernandez-Banet et et et et al. (2014) genome sequencing of 88 HCC tissues from Chinese patients and adja-
cent non-tumor liver tissues revealed 4314 rearrangements, including insertion, deletion, inversion and translocation. 
Two recurrence fusion genes ABCB11 and LRP2 were also found. 
(5) Researchers using genome-wide sequencing of serum from patients with pancreatic cancer find that their serum 
spans genomic DNA across all chromosomes. Serum genome-wide sequencing can be used to identify DNA mutations 
in patients with pancreatic cancer, and to predict, treat, and assess treatment resistance (Kahlert et al., 2014) ). 
With the development of various diagnostic techniques, the detection rate of tumors is increasing. However, the 
specific etiology of tumors has been a worldwide problem. A large number of studies have found that the use of whole 
genome sequencing has found a lot of tumor pathogenesis, which provides a new theoretical basis for the treatment and 
prevention of cancer. 
1.3 Infectious diseases 
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Infectious diseases are very common, even without enough attention. Infectious diseases are caused by bacteria, 
viruses, mycoplasma, chlamydia, rickettsia, spirochetes, fungi, parasites and so on. At present, genome-wide sequencing 
is mainly used to study the mechanism of drug resistance in bacterial infections. 
(1) Li et al. (2014) Comparing the genome of Staphylococcus capitatum subspecies LNZR-1 with that of five other 
Staphylococcus capitatum subspecies strains, a large number of biotin resistance genes were found in the subspecies 
LNZR-1. 
(2) Genome-wide sequencing of cyanobacterial ester-resistant Fusarium graminearum strain YP-1, other cyano-
bacterial ester-sensitive Fusarium graminearum strains and other cyanobacterial ester-resistant Fusarium graminearum 
strains revealed that the gene encoding myosin-5 (point mutation 216, 217, 4) was present in the resistant strains. 
18,420,786) mutation, homologous double-exchange sensitive strain and drug-resistant strain myosin-5 locus, suscepti-
ble bacteria and drug-resistant bacteria showed the opposite performance, it can be seen that myosin-5 mutation caused 
Fusarium graminearum to insecticide cyanide ester resistance (Zheng et al., 2015). 
(3) Xiao Qiancheng et al. (2014) Sequencing of the whole genome of Streptomyces metallococcus revealed that 
the genes encoding transglutaminase-proactivator-related proteins were identified and the secondary metabolite synthe-
sis gene clusters were predicted, which provided basic data for the functional genomics research of Streptomyces me-
tallococcus. 
With the abuse of antibiotics leading to the resistance of many strains to antibiotics, many patients have lost their 
lives because of drug resistance. However, the specific mechanism of drug resistance is still unclear. The use of ge-
nome-wide sequencing technology provides a new detection method for discovering the mechanism of drug resistance, 
which is a big step forward to solve the problem of drug resistance. 
1.4 Communicable epidemics 
Infectious diseases refer to infectious diseases caused by pathogenic microorganisms that can cause epidemics un-
der certain conditions. Genome-wide sequencing is widely used in epidemiological investigation of malaria, tuberculo-
sis and other infectious diseases, and in the study of drug resistance mechanism. 
(1) Logue et al. (2015) analyzed the whole genome of the blood or tissues of four species of malaria mosquitoes 
caught outside Papua New Guinea. Historic mutation studies using homologous DNA sequences larger than 50 Mb to 
assess contemporary gene flow and population size suggested that despite their morphological, behavioral and ecologi-
cal similarities It is their group of malaria mosquitoes that evolved independently in the same area. 
(2) Whole genome sequencing and partial genome sequencing and genotyping of 236 HBV positive samples from 
two of Pakistan's largest provinces (Punjab, Sindh) revealed that genotype D subtype D1 was the most prevalent strain 
of HBV; the most common mutation among HBV carriers was 8 bp deletion mutation (4 out of 23 genotype D samples 
showed C promoter region deletion in nucleotide 1763-1 774 (n = 2), 1 766-1 773 (n = 1) and 1 767-1 774 (n = 1) 8 bp), 
A1915T mutation was detected in all samples, and G1679A mutation (86.96%) was detected in genotype D samples 
(Ahmed et al., Ahmed et al. 2009). 
(3) Walker et al. (2014) used genome-wide sequencing in Oxfordshire to investigate the epidemiology of tubercu-
losis transmission in an unselected population during 2007-2012 and found that people born in low-incidence countries 
were more likely to develop pulmonary disease (adjusted odds of this association were 1.8, 95% CI 1.2-2.9, P = 0.009), 
social risk factors 4, 9 5% CI 2.0~9.4, P < 0.0001. Systematic barriers for new entrants may further improve TB control, 
most importantly for everyone who still needs good health care, especially for high-risk groups. 
(4) Genome-wide sequencing of 47 pairs of patients with tuberculosis (one pair was previously treated; the other 
either failed at 17 weeks of treatment or had a relapsing infection) compared the number and location of single nucleo-
tide polymorphisms in each pair of patients, and found that genome-wide sequencing was useful in differentiating be-
tween relapsed and reinfected patients. With greater resolution, it provides additional clear definitions of endpoints for 
clinical trials (Bryant et al., 2013). 
(5) Witney et al. (2015) In London Teaching Hospital from 2008 to 2014, genome-wide sequencing of 6 suspected 
highly drug-resistant TB patients revealed that M gene mutations in Mycobacterium tuberculosis were associated with 
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drug resistance. 
Infectious diseases have always been a hidden killer endangering people's health, then, the prevention and control 
of infectious diseases has become particularly important, the use of genome-wide sequencing for the prevention, diag-
nosis and treatment of infectious diseases to provide new ideas. 
1.5 Identify individual disease susceptibility 
Whole-genome sequencing of individuals can make patients susceptible to those diseases, which allows individu-
als to prevent early, reduce the prevalence and improve the quality of life. 
(1) Peters et al. (2015) found that each embryo caused less than 10 of these errors (a single basic mutation associ-
ated with one error per GB has a false positive rate) by genome-wide sequencing of 5-10 cells from two blastocyst-stage 
embryos, two parents and grandparents. This is the first evidence that genome-wide sequencing can be used. In order to 
accurately identify new mutations, whole genome sequencing using barcode DNA could be used in the future as part of 
preimplantation genetic diagnostic methods. 
(2) Researchers spent 50 hours in a neonatal intensive care unit in which two babies were clinically differentiated 
from family genetic disorders by functional automated bioinformatics analysis of the entire genome. They found 
GJB2-related severe skin disorders in one infant and BRAT1-related fatal newborns in another. Saunders et al. (2012). 
It can be seen that the discovery of pathogenic gene mutations and the rapid differential diagnosis of diseases by 
genome-wide sequencing of blastocyst embryos and neonates can reduce the incidence of disease and empirical treat-
ment, and provide faster genetic progress and prognostic counseling. 
1.6 Biological evolution 
Evolution has always been the subject of human exploration, which can find the origin of biological species. 
Whole genome sequencing can find the theoretical basis of biological evolution by comparing genome structure and 
using evolutionary analysis, which provides a new method for finding disease-related genes. 
(1) Bnyai et al. (2014) genome-wide sequencing of a respiratory enterovirus isolated from a green Bush venomous 
snake revealed that Bush venomous reovirus and hepatoencephalomyelitis virus share several common characteristics, 
including its genomic structure. Evolutionary analysis showed that the strain, Blum virus and baboon reovirus were 
monogenic, suggesting that these viruses might have originated from a common ancestor. 
(2) Researchers compared the whole genome sequences of Tibetan macaque (M. thibetana, TM), two Chinese rhe-
sus macaques (CR) and two rhesus monkeys (Cynomol gusmacaque, M. fascicularis, CE) and found that TM had 39 
million single nucleotide specific mutations. Some genes carry TM-specific homozygous nonsy-mous variants 
(TSHNVs), and each TSHNVs carries at least 273 immune response and disease-related genes (Fan et al., 2014). 
(3) Li et al. (2014) * using genome sequencing to explore the genetic relationship between European black and 
white pigs and the races distributed around the globe, we found that many of the non synonymous substitutions single 
nucleotide polymorphisms loci contained genes into olfactory related categories. Evolutionary analysis revealed a 
deeper separation between * * pigs between Europe and Asia than between domestic and wild pigs. Analysis of the ad-
mixture shows that the native black and white pigs in Europe show a higher portion of the Chinese genetic material, 
which is consistent with the historical record of its origin. Selective scan analysis showed that strong selection charac-
teristics affected the basic adaptive genomic regions of survival genes: disease resistance, pork production, fertility, 
meekness and body length. These findings confirm the origin history of European black and white pig * and clarify how 
to domesticate the pattern of genetic variation through genome wide analysis. 
Since Darwin put forward the theory of evolution, human beings have been exploring the mechanism of human 
evolution, and using whole genome sequencing can provide some new means of exploring the theory of biological evo-
lution. 
2. Summary and Outlook 
In summary, genome-wide sequencing has been widely used in genetic diseases, tumors, infectious diseases, infec-
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tious epidemics, judging individual disease susceptibility, biological evolution and so on. It provides a new theoreti-
cal basis for disease prevention, pathogenesis, diagnosis and treatment, and provides a new method for human to com-
bat diseases. However, Machini et al. (2014) conducted an anonymous survey of 221 genetic counsellors (including 
genetic counsellors, geneticists, and nurses) about genome-wide sequencing, and found that there were still billing 
problems, genetic interpretation, and the significance of unknown mutations in genome-wide sequencing. There are still 
many problems to solve in order to apply genome sequencing to clinical and real life. It is hoped that through human 
efforts, the whole genome sequencing will eventually be applied to clinical practice, which will facilitate the prevention, 
diagnosis and treatment of clinical diseases and ultimately improve the quality of life of the people. 
References 
1.  ahmed c.s., wang z.h., e.g., chen jj, kamal, m., and hou j. hepatitis b virus genotypes, subgenotypes, precore, 
and basal core promoter mutations in the two largest provinces of pakistan, j. gastroenterol. hepatol., 2009, 24 (4): 
569 - 573 
2.  bányai k., borzák r., ihász k., fehér e., dán 魣., jakab, f., pappt., hetzel u. marschang r.e., and farkas, s.l. whole ge-
nome sequencing of a green bush viper reovirus reveal a shared evolutionary history betweenreptilian and unusual 
mammalian orthoreoviruses, arch. virol 2014, 159 (1): 153 - 163 
3.  bryant. harris s.r., parkhill j., dawson r., diacon a. h, van helden, p., pym a., mahayiddin a.a., chuchottaworn c., 
sanne i.m., louw, c., boeree mj, hoelscher m. mchugh t.d., bateson. hunt rd., mwaigwisya p. wright l. gillespie s.h., 
and bentley s.d. Whole genome sequencing to establish relapse or re infec with mycobacterium tuberculosis and a 
retrospectiveobser - vational study, lancet respir. med 2013, 1 (10): 786 - 792 
4.  fernandez banet, j., lee, n.p., chan, k.t., gao h, liu x, sung v.k., tan w., fan s.t., poon r.t., li p., ching k., rejto per an-
num, mao, m., and kan for decoding complex pat - terns of genomic rearrangement in hepatocellular carcinoma, 
genomics 2014; 103 (2 - 3): 189 - 203 
5.  funayama m. ohe k. amo t., furuya, n., yamaguchi j, we see, li y., ogaki k, ando, m., yoshino is tomiyama h., set-
ting-up - ioka k. hasegawa k, we h. satake w., mogushi k. sasaki, r., kokubo y., kuzuhara s. toda. mizuno, y., 
uchiyama y. ohno, sir k. and hattori n. chchd2 in utosomal dominant late onset parkinson's dis ease: a genome wide 
linkage andsequencing study, lancet neurol 2015; 14 (3): 274 282 
6.  "e. schultz, n., gopalan a. carver b.s., m. t. chang, xiao y., heguy a. huberman, k., bernstein, m., software murali m., 
r. a., vickers, scardino p.t., sander c. v. taylor, reuter, b.s., and sawyer c.l. copy number al teration burden predicts 
prostate cancer relapse, proc. natl. acad. sci. u.s. 2014, 111 (30): 11139 - 11144 
7.  kahlert c. melo s.a., protopopov a., tang j., seth s. cook, m., zhang, j., weltz, j., tian l., futreal a., and kalluri r. the 
identification of double stranded genomic dna spanning all chromosomes with mutated kras and p53 dna in the se-
rum of patients with exosomes pancreatic cancer j. biol. chem 2014, 289 (7): 3869 adopted 
8.  kim h., zheng s, amini s.s., virk s.m., mikkelsen t. make d. j., grimsby, j., sougnez c. muller, f., hu j. sloan a.e., co-
hen m.l. van meir, e.g., scarpace l. laird per week, we instein j.n., lander e.s., gabriel s., getz g. meyerson, m., tian 
l., barnholtz sloan j.s., and verhaak r.g. the sequencing of genomes and multisector exome prima - ry and post 
treatment of glioblastoma reveal patterns of tumor evolution, genomes res., 2015. 25 (3): 316 - 327 
9.  li, m., tian s. yeung ck, meng x, tang q, niu l., wang x.,jin l, ma j., long, k., zhou c, cao y. zhu, l., bai, l., tang g, gu y. 
jiang, a., li x, li r. Whole genome sequencing of berkshire (european native pig) provides insights into its origin and 
domestication, sci. also, 2014, 4 (4678): 1 - 7 
10.  li x, lei song, m., y., gong li, l., h. k., liang and jiang x. whole genome sequence and comparative genomic analysis 
of multidrug resistant staphylococcus capitis subsp. urealyticus strain lnzr - 1, good pathog 2014, 6 (1): 45. 
11.  logue k. small s.t. chan er, reimer, l., siba p.m., rooms - one per year, and serre, d. to whole genome sequencing 
reveal absence of recent geneflow and separate demographer ic histories for anopheles punctulatus mosquitoes in 
papua new guinea, mol. ecol., 2015, 24 (6): 1263 - 1274 
12.  machini k., douglas j. braxton a., tsipis, j., and kramer k. genetic counselors' views and experiences with the clini-
cal integration of genome sequencing, j. genet. couns 2014, 23 (4): 496 - 505 
13.  mohd - yusoff new numbering, ruperao p., tomoyoshi n.a., edwards, d., gresshoff p.m., biswas b., and batley, j. 
scanning the effects of ethyl methanesulfonate on the whole genomes of lotus japonicus using second generation 
sequencing anal ysis, g3 (bethesda), 2015, 5 (4): 559 - 567 
14.  mroz et al., tward a.m., smidt r.j., ren y., and rocco jw. intra tumor genetic heterogeneity and mortality in head and 
neck cancer: analysis of data from the cancer genome atlas, plos med 2015, 12 (2): e1001786 
15.  nemirovsky s.i., cordoba, m., zaiat jj, air s.p., vega, p. a., gonzalez - morón d., medina, n.m., fabbro m. s., 
romero, brun b., revale p., ogara m.f., pecci a., marti m, vazquez, m., turjanski a., and kauffman. whole genome 
sequencing reveal a de novo shank3 mu works in fam iwl autism spectrum disorder, plos one, 2015, 10 (2): 
e0116358 
16.  Peters B.A., Kermani B.G., Alferov O., Agarwal, M. R., Mcel Wain - B.A., Gulbahce N. Hayden, D.M., Zhang 
Tang y.t. tearle, R.Y., R., Crain B., R. A. Munné Prates, Berkeley, S., and R. drmanac, and Phasing, Detection of 
 6 | Marico Wagner et al. Genetic Disease Study 
Single Base mutations in biopsies Novo from human in vitro fertilized Embryos byadvanced whole - Genome se-
quencing, Genome Res 2015  25 (3): 427 - 434 
17.  Saunders C.J., Miller N.A., Soden S.E., Dinwiddie, D.L., Noll A., alnadi N.A., andraws N. Patterson, M.L., 
krivohlavek L.A. humphray Fellis, J., S., Saffrey P. Kingsbury, Z., J. J. Weir, Betley grocock Margulies, R.J., E.H., 
e.g. Artman Farrow, M., Safina N.P., petrikin J.E. Hall, K.P., and ki Ngsmore S.F., Rapid Whole Genome sequenc-
ing for Genetic disease diagnosis in Neonatal Intensive Care Units, SCI. Transl. Med 2012, 4 (154): 154ra135 
 
